AC8 0.00% 4.0¢ auscann group holdings ltd

AusCann up more than 65pc after completing testing of hard-shell capsules, page-63

  1. 755 Posts.
    lightbulb Created with Sketch. 186
    Any idea why they are conducting the trials of their hard shell capsules at Singapore General Hospital and not somewhere in Australia?

    It would appear that approvals and recruiting patients would be more challenging in SGH because of the negative sentiment towards all drugs there.

    Anyone care to shed any light?

 
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.